No Data
Global Equities Roundup: Market Talk
PhillipCapital Upgrades Raffles Medical Group to Accumulate From Neutral, Adjusts Price Target to SG$1.02 From SG$0.96
UOB Kay Hian Upgrades Raffles Medical Group to Buy From Hold, Adjusts Price Target to SG$1.06 From SG$1.01
Raffles Medical Group's Strong Financial Performance and Growth Potential Justifies Buy Rating
Raffles Medical Group's China Hospitals Expected to Break Even in 2026 -- Market Talk
Raffles Medical Group Raised to Buy From Hold by Maybank Securities >BSL.SG
